z-logo
open-access-imgOpen Access
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab
Author(s) -
Markus Moehler,
Christian Frings,
Annett Mueller,
Ines Gockel,
Carl C. Schimanski,
Stefan Biesterfeld,
Peter R. Galle,
Martin Holtmann
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.4156
Subject(s) - cetuximab , colorectal cancer , epidermal growth factor receptor , medicine , cancer research , immunohistochemistry , vascular endothelial growth factor , lymph node , lymphangiogenesis , receptor , cancer , oncology , pathology , vegf receptors , metastasis
To gain mechanistic insights into the role played by epidermal growth factor receptor (EGFR) in the regulation of vascular endothelial growth factors (VEGFs) in colorectal cancer (CRC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here